What Latest Market Dip Means for Cannabis Investors
Today, I discuss this recent market dip and what it means for cannabis investors. September has been a rough month for the stock market. In…
On the Radar Reports
Toast IPO Preview: Restaurant Revival May Boost This Software Co.
Toast IPO Preview The initial public offering (IPO) market is active again, with many new offerings set to price in the coming days. I want…
The Global Cannabis Trend + New Leaf Stock (NLVVF) Analysis
Today, I address: The increasing number of cannabis users around the world. A reader question about Canadian cannabis company New Leaf Ventures and its underlying…
COVID-19 Vaccine Stocks: Is Inovio Still In Play?
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising pInovio Pharmaceuticals went from being…
All Psyched Up: A Current List Of Psychedelics Stocks To Watch
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising potential of psychedelic medicine drug…
2 Former Wall Street Pros Share Their 5 Innovative Stocks To Buy
At the recent Global Financial Summit, two former Wall Street professionals shared their picks for innovative stocks to buy for the opportunity to profit from…
When It Comes To These 2 Biopharma Stocks’ Near-Term Gains, Analysts Are Seeing (More Than) Double!
Today’s article highlights two clinical-stage biopharmaceutical stocks that analysts expect to more than double in the coming months — one engaged in discovering and developing…
Key Events – And Potential Catalysts – For Biotech Stocks This Week
After a week that saw mostly strong earnings reports from big pharma companies, an Alzheimer’s conference that moved stocks, and a slew of IPOs of…
These 19 “Moaty” Small-Caps Are High-Quality & Undervalued
Smaller-cap companies have had a good 12 months, and the author of today’s article notes that “the return picture over the trailing three-year period suggests…
Will August Bring FDA Approvals For These Biotech Stocks?
With just a few days remaining in July, the FDA has approved four novel drugs this month, including a treatment for a parasitic “sleeping sickness”…